Technical Evaluation of Commercial IMUs Within Clinical Gait Analysis
ConditionGait Analysis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorRoessingh Research and Development
About this trial
A standard clinical gait analysis consists of observing walking with video (2D) or advanced equipment (VICON 3D). This 3D method provides detailed information about the gait pattern, but is time-consuming in implementation and data analysis. There are commercial 3D systems on the market that are used in healthy individuals and in sports. These so-called Inertial Measurement Units (IMUs) may also be suitable for use in the clinic. In this research protocol, the aim is to test the usability of commercial sensors and technically compare them with standard clinical 3D gait analysis in adult patients with a neurological disorder.
Eligibility criteria
Qualifiers
Disorders affecting walking, including amongst others stroke, traumatic brain injury, MS, incomplete spinal cord injury, CP, Spina Bifida, neuromuscular diseases
age minimum 18 years
Viosca score minimum 2; meaning minimal independent walking ability indoors
increased fall risk or increased effort of walking because of: 1) decreased stability during stance; and/or 2) decreased foot clearance during swing; and/or 3) not able to walk on bare feet because of equinovarus; and/or 4) fatigue during walking because of compansatory strategies.
Disqualifiers
subjects referred for clinical gait analysis because of problems other than stiff knee gait or foot surgery
severe deficits in communication, memory and understanding at such a level that it would affect instructions during the measurements
Trial design
Treatments tested in this trial
- gait analysis using 3D (Vicon) and IMU (Movella)
Treatment groups
40 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov